Clinical trial
Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic…
NCT03192332 · Insel Gruppe AG, University Hospital Bern, Other · Completed
Key facts
| NCT number | NCT03192332 |
|---|---|
| Title | Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic Stroke |
| Official title | Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke |
| Acronym | SWIFT DIRECT |
| Lead sponsor | Insel Gruppe AG, University Hospital Bern, Other |
| Collaborators | Medtronic Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Ischemic Stroke |
| Intervention type | Device, Drug |
| Interventions | Stent-retriever thrombectomy with revascularization device of the Solitaire™ type, Intravenous thrombolysis with recombinant tissue-type plasminogen activator (IV t-PA) |
| Enrollment | 410 |
| Start date | Nov 29, 2017 |
| Primary completion | May 14, 2021 |
| Completion | Aug 11, 2021 |
| First posted | Jun 20, 2017 |
| Last update posted | Nov 14, 2024 |
| Countries | Austria, Canada, Finland, France, Germany, Spain, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: